Survey of the seroprevalence and infection status of SARS-CoV-2 among employees of the University Hospital Jena (COVID-19)

Survey of the seroprevalence and infection status of SARS-CoV-2 among employees of the University Hospital Jena (COVID-19) - Co-HCW

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00022432

Enrollment

300

Registered

2020-07-20

Start date

2020-05-19

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

U07.1 COVID-19

Interventions

Group 1: Employees of the UKJ Jena from areas with and without patient contact are tested for Covid-19 seroprevalence at 3 measurement points and compared how high the risk of nosocomial infection ver

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Employee at the UKJ. Presence of informed consent to participate in the study.

Exclusion criteria

Exclusion criteria: none

Design outcomes

Primary

Measure	Time frame
The Co-HCW study is intended to investigate the Covid-19 seroprevalence of employees of the University Hospital Jena longitudinally (3 measurement points at intervals of 4-6 months each).	—

Secondary

Measure	Time frame
Clinical areas with CoVID-19 patients will be compared with areas without patient contact. The risk of nosocomial infection and of infection outside the UKJ will be assessed by means of a questionnaire.	—

Countries

Germany

Contacts

Public ContactChristina Bahrs

Universitätsklinikum Jena, Institut für Infektionsmedizin und Krankenhaushygiene

Christina.Forstner@med.uni-jena.de+49 3641 9 324769

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026